Browse > Article
http://dx.doi.org/10.4014/jmb.1410.10041

Cloning, Expression, and Purification of Recombinant Uricase Enzyme from Pseudomonas aeruginosa Ps43 Using Escherichia coli  

Shaaban, Mona I. (Microbiology Department, Faculty of Pharmacy, Mansoura University)
Abdelmegeed, Eman (Microbiology Department, Faculty of Pharmacy, Mansoura University)
Ali, Youssif M. (Microbiology Department, Faculty of Pharmacy, Mansoura University)
Publication Information
Journal of Microbiology and Biotechnology / v.25, no.6, 2015 , pp. 887-892 More about this Journal
Abstract
Uricase is an important microbial enzyme that can be used in the clinical treatment of gout, hyperuricemia, and tumor lysis syndrome. A total of 127 clinical isolates of Pseudomonas aeruginosa were tested for uricase production. A Pseudomonas strain named Ps43 showed the highest level of native uricase enzyme expression. The open reading frame of the uricase enzyme was amplified from Ps43 and cloned into the expression vector pRSET-B. Uricase was expressed using E. coli BL21 (DE3). The ORF was sequenced and assigned GenBank Accession No. KJ718888. The nucleotide sequence analysis was identical to the coding sequence of uricase gene puuDof P. aeruginosa PAO1. We report the successful expression of P. aeruginosa uricase in Escherichia coli. E. coli showed an induced protein with a molecular mass of about 58 kDa that was confirmed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and Western blotting. We also established efficient protein purification using the Ni-Sepharose column with activity of the purified enzyme of 2.16 IU and a 2-fold increase in the specific activity of the pure enzyme compared with the crude enzyme.
Keywords
Uricase; expression; recombinant; P. aeruginosa; western blot;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Zhang P, Lu X, Li Q, Lin X, Liu H, Ma X. 2012. Cloning and characterization of a thermostable urate oxidase from Microbacterium sp. strain ZZJ4-1. Sheng Wu Gong Cheng Xue Bao 28: 813-822.
2 Richette P, Bardin T. 2010. Gout. Lancet 375: 318-328.   DOI   ScienceOn
3 Saeed HM, Abdel-Fattah YR, Gohar YM, Elbaz MA. 2004. Purification and characterization of extracellular Pseudomonas aeruginosa urate oxidase enzyme. Pol. J. Microbiol. 53: 45-52.
4 Schiavon O, Caliceti P, Ferruti P, Veronese FM. 2000. Therapeutic proteins: a comparison of chemical and biological properties of uricase conjugated to linear or branched poly (ethylene glycol) and poly (N-acryloyl morpholine). Farmaco 55: 264-269.   DOI   ScienceOn
5 Shin HY, Kang HJ, Park ES, Choi HS, Ahn HS, Kim SY, et al. 2006. Recombinant urate oxidase (rasburicase) for the treatment of hyperuricemia in pediatric patients with hematologic malignancies: results of a compassionate prospective multicenter study in Korea. Pediatr. Blood Cancer 46: 439-445.   DOI   ScienceOn
6 SitiHatijah PM, Wan Ruhayu WR. 2013. Preliminary study on factors that enhanced the production of uricase by Aspergillus flavus. Int. J. Biosci. Biochem. Bioinform. 3: 513-515.
7 Vogt B. 2005. Urate oxidase (rasburicase) for treatment of severe tophaceous gout. Nephrol. Dial. Transplant. 20: 431-433.   DOI   ScienceOn
8 Woods DE, Schaffer MS, Rabin HR, Campbell GD, Sokol PA. 1986. Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites. J. Clin. Microbiol. 24: 260-264.
9 Wretlind B, Pavlovskis OR. 1983. Pseudomonas aeruginosa elastase and its role in Pseudomonas infections. Rev. Infect. Dis. 5: S998-S1004.   DOI
10 Zhang J, Ren J, Li B, Liu S, Hou L, Fu L, et al. 2010. Construction, expression, purification and characterization of mutant of Aspergillus flavus urate oxidase. Sheng Wu Gong Cheng Xue Bao 26: 1102-1107.
11 Li J, Chen Z, Hou L, Fan H, Weng S, Xu C, et al. 2006. High-level expression, purification, and characterization of non-tagged Aspergillus flavus urate oxidase in Escherichia coli. Protein Expr. Purif. 49: 55-59.   DOI   ScienceOn
12 Jagger KS, Bahner DR, Warren RL. 1983. Protease phenotypes of Pseudomonas aeruginosa isolated from patients with cystic fibrosis. J. Clin. Microbiol. 17: 55-59.
13 Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.   DOI   ScienceOn
14 Lehejckova R, Demnerova K, Kralova B. 1986. Screening of microorganisms with uricase activity. Biotechnol. Lett. 8: 341-342.   DOI
15 Lyczak JB, Cannon CL, Pier GB. 2000. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microbes Infect. 2: 1051-1060.   DOI   ScienceOn
16 Nishiya Y, Hibi T, Oda J. 2002. A purification method of the diagnostic enzyme Bacillus uricase using magnetic beads and non-specific protease. Protein Expr. Purif. 25: 426-429.   DOI   ScienceOn
17 Oda M, Satta Y, Takenaka O, Takahata N. 2002. Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol. Biol. Evol. 19: 640-653.   DOI   ScienceOn
18 Pfrimer P, de Moraes LM, Galdino AS, Salles LP, Reis VC, De Marco JL, et al. 2010. Cloning, purification, and partial characterization of Bacillus subtilis urate oxidase expressed in Escherichia coli. J. Biomed. Biotechnol. 2010: 674908.   DOI
19 Pui CH, Mahmoud HH, Wiley JM, Woods GM, Leverger G, Camitta B, et al. 2001. Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma. J. Clin. Oncol. 19: 697-704.   DOI
20 Colloc’h N, el Hajji M, Bachet B, L’Hermite G, Schiltz M, Prange T, et al. 1997. Crystal structure of the protein drug urate oxidase-inhibitor complex at 2.05 A resolution. Nat. Struct. Biol. 4: 947-952.   DOI   ScienceOn
21 Elmer K, Washington W, Jr Stephen A, William J, Gary P, Paul S, Gail W. 2006. Koneman's Color Atlas and Textbook of Diagnostic Microbiology, 6th Ed. Lippincott Williams and Wilkins, London.
22 Essam AA, Ali M, Fareed M. 2005. Studies on uricase induction in certain bacteria. Egyptian J. Biol. 7: 44-54.
23 Fazel R, Zarei N, Ghaemi N, Namvaran MM, Enayati S, Mirabzadeh Ardakani E, et al. 2014. Cloning and expression of Aspergillus flavus urate oxidase in Pichia pastoris. Springerplus 3: 395.   DOI   ScienceOn
24 Feig DI, Kang DH, Johnson RJ. 2008. Uric acid and cardiovascular risk. N. Engl. J. Med. 359: 1811-1821.   DOI   ScienceOn
25 George RL, Jr Sundy JS. 2012. Pegloticase for treating refractory chronic gout. Drugs Today (Barc). 48: 441-449.
26 Hogardt M, Heesemann J. 2010. Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung. Int. J. Med. Microbiol. 300: 557-562.   DOI   ScienceOn
27 Hummel M, Buchheidt D, Reiter S, Bergmann J, Adam K, Hehlmann R. 2005. Recurrent chemotherapy-induced tumor lysis syndrome (TLS) with renal failure in a patient with chronic lymphocytic leukemia - successful treatment and prevention of TLS with low-dose rasburicase. Eur. J. Haematol. 75: 518-521.   DOI   ScienceOn
28 Ishikawa J, Yamashita A, Mikami Y, Hoshino Y, Kurita H, Hotta K, et al. 2004. The complete genomic sequence of Nocardia farcinica IFM 10152. Proc. Natl. Acad. Sci. USA 101: 14925-14930.   DOI   ScienceOn
29 Ali UF, Ibrahim ZM. 2013. Effect of irradiation on uricase produced by two strains of Asperigillus niger. Life Sci. J. 10: 962-967.
30 Adamek V, Kralova B, Suchova M, Valentova O, Demnerova K. 1989. Purific ation of mic robial uric ase. J. Chromatogr. 497: 268-275.   DOI   ScienceOn
31 Anderson A, Vijayakumar S. 2012. Isolation and optimization of Pseudomonas aeruginosa for uricase production. Int. J. Pharma Biol. Sci. 3: 143-150.
32 Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.   DOI   ScienceOn
33 Cammalleri L, Malaguarnera M. 2007. Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout. Int. J. Med. Sci. 4: 83-93.   DOI
34 Chen M, Cai L, Fang Z, Tian H, Gao X, Yao W. 2008. Sitespecific incorporation of unnatural amino acids into urate oxidase in Escherichia coli. Protein Sci. 17: 1827-1833.   DOI   ScienceOn
35 Chen Z, Wang Z, He X, Guo X, Li W, Zhang B. 2008. Uricase production by a recombinant Hansenula polymorpha strain harboring Candida utilis uricase gene. Appl. Microbiol. Biotechnol. 79: 545-554.   DOI
36 Chohan S, Becker MA. 2009. Update on emerging uratelowering therapies. Curr. Opin. Rheumatol. 21: 143-149.   DOI   ScienceOn